HL McLeod
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 4
- Biochemistry top 5%
- Internal Medicine top 10%
- Statistics and Probability top 5%
-
- Metabolism and Genetic Disorders 3
-
- Colorectal Cancer Treatments and Studies 3
- Cancer Treatment and Pharmacology 3
- HER2/EGFR in Cancer Research 2
-
- Cancer therapeutics and mechanisms 2
-
- Genetic factors in colorectal cancer 2
-
- Diet and metabolism studies 2
HL McLeod
14 papers receiving 909 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Pharmacology 563
- Biochemistry 90
- Endocrinology, Diabetes and Metabolism 191
- Internal Medicine 33
- Statistics and Probability 68
Countries citing papers authored by HL McLeod
This map shows the geographic impact of HL McLeod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HL McLeod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HL McLeod more than expected).
Fields of papers citing papers by HL McLeod
This network shows the impact of papers produced by HL McLeod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HL McLeod. The network helps show where HL McLeod may publish in the future.
Co-authorship network
The 25 scholars most cited alongside HL McLeod, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 15 | |
| 2 | Capecitabine Therapy and DPYD Genotype -- Medical Genetics Summaries | 2012 | 1 |
| 3 | Warfarin Therapy and VKORC1 and CYP Genotype -- Medical Genetics Summaries | 2012 | 1 |
| 4 | Clobazam Therapy and CYP2C19 Genotype -- Medical Genetics Summaries | 2012 | 0 |
| 5 | Fluorouracil Therapy and DPYD Genotype -- Medical Genetics Summaries | 2012 | 3 |
| 6 | Clozapine Therapy and CYP2D6, CYP1A2, and CYP3A4 Genotypes -- Medical Genetics Summaries | 2012 | 2 |
| 7 | Tramadol Therapy and CYP2D6 Genotype -- Medical Genetics Summaries | 2012 | 2 |
| 8 | Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarinbreakdown → | 2008 | 595 |
| 9 | 2008 | 9 | |
| 10 | 2007 | 30 | |
| 11 | 2006 | 33 | |
| 12 | 1997 | 7 | |
| 13 | 1996 | 32 | |
| 14 | 1996 | 18 | |
| 15 | 1995 | 179 |
About HL McLeod
HL McLeod is a scholar working on Pharmacology, Clinical Biochemistry, Oncology, Pediatrics, Perinatology and Child Health and Anesthesiology and Pain Medicine, having authored 15 papers that have together received 927 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Metabolism and Genetic Disorders (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (3 papers), Cancer therapeutics and mechanisms (2 papers), HER2/EGFR in Cancer Research (2 papers), Genetic factors in colorectal cancer (2 papers) and Diet and metabolism studies (2 papers). The work is most often cited by research in Pharmacology (563 citations), Biochemistry (90 citations), Endocrinology, Diabetes and Metabolism (191 citations), Internal Medicine (33 citations) and Statistics and Probability (68 citations). HL McLeod has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Evans We, M V Relling, CH Pui, Ann C. Barrett, Gloria R. Grice, P. M. Ridker, C.L. Aquilante, DL Veenstra, Brian F. Gage and Paul E. Milligan. Their work appears in journals such as British Journal of Cancer, Clinical Pharmacology & Therapeutics, Pharmacogenomics, The Journal of Pathology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.